TFS Capital’s Fortress Biotech FBIO Stock Holding History

TFS Capital’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-21,041	Closed	-$830K	–	1415
2013 Q4	$830K	Buy	+21,041	New	+$812K	0.04%	631

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Advent Capital Management New York $3.63B AUM 0.29% 1-Year Est. Return

TFS Capital's FBIO Position: Q1 2014 in Review

TFS Capital sold out of Fortress Biotech (FBIO) in Q1 2014, closing a stake of 21,041 shares — an estimated $830K sold.

TFS Capital first reported a position in FBIO in Q4 2013 and held it in 1 quarter. The position peaked at $830K in Q4 2013. 57 funds tracked by Wall St. Rank hold FBIO as of Q1 2014.

TFS Capital reported no remaining Fortress Biotech position as of Q1 2014 after selling out during the quarter.
TFS Capital sold 21,041 Fortress Biotech shares in Q1 2014, an estimated $830K.
TFS Capital first reported a position in Fortress Biotech in Q4 2013 and held it in 1 quarter.
TFS Capital's Fortress Biotech position peaked at $830K in Q4 2013.
57 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2014.

Based on TFS Capital's 13F filing for Q1 2014, filed 5 May 2014.